Loading…

Construction, expression and purification of a novel CadF–based multiepitope antigen and its immunogenic polyclonal antibody specific to Campylobacter jejuni and Campylobacter coli

Campylobacteriosis is a disease in humans caused by the infection from Campylobacter spp. Human cases are mainly due to Campylobacter jejuni, although C. coli can cause gastroenteritis in humans as well. The bacteria are commensal in chicken tract and can be contaminated into chicken products during...

Full description

Saved in:
Bibliographic Details
Published in:Protein expression and purification 2021-04, Vol.180, p.105818-105818, Article 105818
Main Authors: Wenbap, Pattarapong, Seetang–Nun, Yortyot, Luangtongkum, Taradon, Khunrae, Pongsak, Tuitemwong, Pravate, Rattanarojpong, Triwit
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Campylobacteriosis is a disease in humans caused by the infection from Campylobacter spp. Human cases are mainly due to Campylobacter jejuni, although C. coli can cause gastroenteritis in humans as well. The bacteria are commensal in chicken tract and can be contaminated into chicken products during processing. Obviously, detecting reagents such as a specific antibody is essential for the development of immune–based detection methods for C. jejuni or C. coli. In this study, in silico techniques were used to design a chimeric recombinant antigen, named multiepitope antigen (MEA), for the production of specific polyclonal antibody. To design MEA polypeptide based on C. jejuni fibronectin–binding protein or CadF, four conserved and unique antigenic peptides were identified and fused together directly. The C. jejuni CadF–based MEA polypeptide fused with two single six–histidine tags at both C– and N–terminal ends was expressed under Escherichia coli expression system. The recombinant MEA was successfully produced and purified by Ni–NTA resin with a high satisfactory yield. Indirect ELISA results showed that anti–MEA polyclonal antibody derived from rabbit serum had a titer of 16,000, indicating high antigenicity of MEA polypeptide. Dot blot results also confirmed that the produced anti–MEA antibody could specifically recognize both C. jejuni and C. coli whole cells as expected while there was no cross–reactivity to non–Campylobacter spp. tested in this study. •In silico chimeric multiepitope antigen (MEA) derived from the conserved region of CadF from C. jejuni CadF was firstly designed.•Production in E. coli and purification of chimeric multiepitope antigen (MEA) with two single six His–tags was successful.•Rabbit pAb specific to chimeric multiepitope antigen (MEA) had specific reactions with C. jejuni and C. coli.
ISSN:1046-5928
1096-0279
DOI:10.1016/j.pep.2021.105818